Related Experiment Video
Updated: Dec 5, 2025

Propagation of Homalodisca coagulata virus-01 via Homalodisca vitripennis Cell Culture
Published on: September 25, 2014
Survival Analysis of Treatment Efficacy in Comparative Coronavirus Disease 2019 Studies
Zachary R McCaw1, Lu Tian2, Dae Hyun Kim3
1Google, Mountain View, California, USA.
Abstract:
For survival analysis in comparative coronavirus disease 2019 trials, the routinely used hazard ratio may not provide a meaningful summary of the treatment effect. The mean survival time difference/ratio is an intuitive, assumption-free alternative. However, for short-term studies, landmark mortality rate differences/ratios are more clinically relevant and should be formally analyzed and reported.
More Related Videos
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
08:41Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Hazard Ratio
For example, in a clinical trial...
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Assumptions of Survival Analysis